Toward Repurposing Metformin as a Precision Anti-Cancer Therapy Using Structural Systems Pharmacology

[1]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[2]  Y. Makino,et al.  Tubular Injury in a Rat Model of Type 2 Diabetes Is Prevented by Metformin , 2011, Diabetes.

[3]  Md. Jamiul Jahid,et al.  A Steiner tree-based method for biomarker discovery and classification in breast cancer metastasis , 2012, BMC Genomics.

[4]  S. Dongen.  Graph clustering by flow simulation , 2000 .

[5]  S. Ramaswamy,et al.  Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.

[6]  Hua Xu,et al.  Deciphering Signaling Pathway Networks to Understand the Molecular Mechanisms of Metformin Action , 2015, PLoS Comput. Biol..

[7]  H. Beug,et al.  Semaphorin-7a reverses the ERF-induced inhibition of EMT in Ras-dependent mouse mammary epithelial cells , 2012, Molecular biology of the cell.

[8]  Yun-Wei Lin,et al.  Inhibition of p38 MAPK-dependent MutS homologue-2 (MSH2) expression by metformin enhances gefitinib-induced cytotoxicity in human squamous lung cancer cells. , 2013, Lung cancer.

[9]  M. Vaysberg,et al.  The serum- and glucocorticoid-induced protein kinase-1 (Sgk-1) mitochondria connection: identification of the IF-1 inhibitor of the F(1)F(0)-ATPase as a mitochondria-specific binding target and the stress-induced mitochondrial localization of endogenous Sgk-1. , 2013, Biochimie.

[10]  Denis Thieffry,et al.  RSAT 2011: regulatory sequence analysis tools , 2011, Nucleic Acids Res..

[11]  S. Safe,et al.  Mechanism of Metformin-dependent Inhibition of Mammalian Target of Rapamycin (mTOR) and Ras Activity in Pancreatic Cancer , 2014, The Journal of Biological Chemistry.

[12]  Philip E. Bourne,et al.  A Multidimensional Strategy to Detect Polypharmacological Targets in the Absence of Structural and Sequence Homology , 2010, PLoS Comput. Biol..

[13]  R. Schroers,et al.  Multikinase inhibitor sorafenib exerts cytocidal efficacy against Non‐Hodgkin lymphomas associated with inhibition of MAPK14 and AKT phosphorylation , 2011, British journal of haematology.

[14]  Wei Wu,et al.  Microarray Analysis Reveals Glucocorticoid-Regulated Survival Genes That Are Associated With Inhibition of Apoptosis in Breast Epithelial Cells , 2004, Cancer Research.

[15]  S. Patterson,et al.  Investigation of the effect of oral metformin on dipeptidylpeptidase‐4 (DPP‐4) activity in Type 2 diabetes 1 , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[16]  Tony Taldone,et al.  Inhibition of dipeptidyl peptidase-IV (DPP-IV) by atorvastatin. , 2008, Bioorganic & medicinal chemistry letters.

[17]  Susumu Goto,et al.  The KEGG resource for deciphering the genome , 2004, Nucleic Acids Res..

[18]  Jen-kun Lin,et al.  Carnosol inhibits the invasion of B16/F10 mouse melanoma cells by suppressing metalloproteinase-9 through down-regulating nuclear factor-kappa B and c-Jun. , 2005, Biochemical pharmacology.

[19]  Nahum Sonenberg,et al.  Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. , 2006, Cancer research.

[20]  A. Paller,et al.  Deacetylated GM3 Promotes uPAR-Associated Membrane Molecular Complex to Activate p38 MAPK in Metastatic Melanoma , 2013, Molecular Cancer Research.

[21]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[22]  Christina Backes,et al.  GeneTrail—advanced gene set enrichment analysis , 2007, Nucleic Acids Res..

[23]  Gavin MacBeath,et al.  A multiscale statistical mechanical framework integrates biophysical and genomic data to assemble cancer networks , 2014, Nature Genetics.

[24]  G. Leclerc,et al.  Metformin Induces Apoptosis through AMPK-Dependent Inhibition of UPR Signaling in ALL Lymphoblasts , 2013, PloS one.

[25]  Philip E. Bourne,et al.  Drug Discovery Using Chemical Systems Biology: Weak Inhibition of Multiple Kinases May Contribute to the Anti-Cancer Effect of Nelfinavir , 2011, PLoS Comput. Biol..

[26]  E. Lengyel,et al.  Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b , 2000, Oncogene.

[27]  M. Pollak,et al.  Metformin directly acts on mitochondria to alter cellular bioenergetics , 2014, Cancer & metabolism.

[28]  P. O'Connor,et al.  Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. , 1994, Science.

[29]  S. Omholt,et al.  Phenomics: the next challenge , 2010, Nature Reviews Genetics.

[30]  Philip E. Bourne,et al.  SMAP-WS: a parallel web service for structural proteome-wide ligand-binding site comparison , 2010, Nucleic Acids Res..

[31]  Lei Xie,et al.  Structural basis of polypharmacological effects of metformin , 2012, 2012 IEEE International Conference on Bioinformatics and Biomedicine Workshops.

[32]  J. Chernoff,et al.  Vav1 Transduces T Cell Receptor Signals to the Activation of the Ras/ERK Pathway via LAT, Sos, and RasGRP1* , 2004, Journal of Biological Chemistry.

[33]  K. Hemminki,et al.  Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer. , 2006, Carcinogenesis.

[34]  Rui Chen,et al.  Promise of personalized omics to precision medicine , 2013, Wiley interdisciplinary reviews. Systems biology and medicine.

[35]  P. Flatt,et al.  Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetes , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[36]  N. Gray,et al.  Targeting cancer with small molecule kinase inhibitors , 2009, Nature Reviews Cancer.

[37]  Daniel S. Himmelstein,et al.  Understanding multicellular function and disease with human tissue-specific networks , 2015, Nature Genetics.

[38]  Philip E. Bourne,et al.  Drug Off-Target Effects Predicted Using Structural Analysis in the Context of a Metabolic Network Model , 2010, PLoS Comput. Biol..

[39]  B. Faubert,et al.  PGC-1α supports glutamine metabolism in breast cancer , 2013, Cancer & Metabolism.

[40]  D. Sutherlin,et al.  Selective Inhibition of Fibroblast Activation Protein Protease Based on Dipeptide Substrate Specificity* , 2006, Journal of Biological Chemistry.

[41]  Xiaowei Yang,et al.  Towards Structural Systems Pharmacology to Study Complex Diseases and Personalized Medicine , 2014, PLoS Comput. Biol..

[42]  Christian von Mering,et al.  STRING 8—a global view on proteins and their functional interactions in 630 organisms , 2008, Nucleic Acids Res..

[43]  S. Kihara,et al.  Adiponectin Stimulates Angiogenesis by Promoting Cross-talk between AMP-activated Protein Kinase and Akt Signaling in Endothelial Cells* , 2004, Journal of Biological Chemistry.

[44]  George Papadatos,et al.  The ChEMBL bioactivity database: an update , 2013, Nucleic Acids Res..

[45]  Jeremy J. W. Chen,et al.  A five-gene signature and clinical outcome in non-small-cell lung cancer. , 2007, The New England journal of medicine.

[46]  Raymond Lo,et al.  Raloxifene attenuates Pseudomonas aeruginosa pyocyanin production and virulence. , 2012, International journal of antimicrobial agents.

[47]  Masahiro Morita,et al.  Distinct perturbation of the translatome by the antidiabetic drug metformin , 2012, Proceedings of the National Academy of Sciences.

[48]  Mingming Jia,et al.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..

[49]  Christian Borgs,et al.  Finding undetected protein associations in cell signaling by belief propagation , 2010, Proceedings of the National Academy of Sciences.

[50]  C. Elmets,et al.  Metformin, an Antidiabetic Agent Reduces Growth of Cutaneous Squamous Cell Carcinoma by Targeting mTOR Signaling Pathway † , 2012, Photochemistry and photobiology.

[51]  Anton J. Enright,et al.  An efficient algorithm for large-scale detection of protein families. , 2002, Nucleic acids research.

[52]  K. Lim,et al.  Tumour maintenance is mediated by eNOS , 2008, Nature.

[53]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[54]  Bridget E. Begg,et al.  A Proteome-Scale Map of the Human Interactome Network , 2014, Cell.

[55]  S. Gabriel,et al.  Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib. , 2014, Cancer discovery.

[56]  P. Donnan,et al.  New Users of Metformin Are at Low Risk of Incident Cancer , 2009, Diabetes Care.

[57]  Lei Xie,et al.  Multiscale modeling of the causal functional roles of nsSNPs in a genome-wide association study: application to hypoxia , 2013, BMC Genomics.

[58]  F. Musumeci,et al.  SI113, a Specific Inhibitor of the Sgk1 Kinase Activity that Counteracts Cancer Cell Proliferation , 2015, Cellular Physiology and Biochemistry.

[59]  Sarah L. Kinnings,et al.  Novel computational approaches to polypharmacology as a means to define responses to individual drugs. , 2012, Annual review of pharmacology and toxicology.

[60]  L. Wagner,et al.  21. UniGene: A Unified View of the Transcriptome , 2003 .

[61]  Sridhar Ramaswamy,et al.  Targeting transcription regulation in cancer with a covalent CDK7 inhibitor , 2014, Nature.

[62]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[63]  Michael Q. Zhang,et al.  Genome-wide map of regulatory interactions in the human genome , 2014, Genome research.